Risk factors for postoperative complications in robotic general surgery

Challenges and Solutions in Postoperative Complications: A Narrative Review in General Surgery

In general surgery, the goal of achieving favorable results following surgical procedures is consistently impeded by the intricate range of postoperative problems. This abstract summarizes a comprehensive narrative study that examines the numerous difficulties associated with postoperative complications and investigates potential remedies. With the progress of surgical practices, the intricacies of complications also increase, requiring a flexible comprehension of the diverse scenarios. This review examines the many factors contributing to postoperative complications, including patient-specific variables and advancing surgical procedures. It also explores the broader consequences of these problems on individual patients and healthcare systems. The economic results, such as extended hospitalizations and increased allocation of resources, highlight the need for specific solutions. This abstract also emphasizes the review's examination of novel methodologies, technology incorporations, and cooperative tactics as potential transformative factors. This abstract provides an overview of the ongoing efforts to change how postoperative complications are understood in general surgery. It highlights the importance of taking preventive measures and adopting a comprehensive approach to patient care.

Adverse Events and Morbidity in a Multidisciplinary Pediatric Robotic Surgery Program. A prospective, Observational Study

OBJECTIVE

To report one-year morbidity of robotic-assisted laparoscopic surgery (RALS) in a dedicated, multidisciplinary, pediatric robotic surgery program. Summary Background Data. RALS in pediatric surgery is expanding, but data on morbidity in children is limited.

METHODS

All children who underwent RALS (Da Vinci Xi, Intuitive Surgical, USA) were prospectively included (October 2016 to May 2020; follow-up ≥1 year). Analyzed data: patient characteristics, surgical indication/procedure, intraoperative adverse events (ClassIntra classification), blood transfusion, hospital stay, postoperative complications (Clavien-Dindo).

RESULTS

Three hundred consecutive surgeries were included: urology/gynecology (n=105), digestive surgery (n=83), oncology (n=66), ENT surgery (n=28), thoracic surgery (n=18). Median age and weight at surgery were 9.5 [interquartile range (IQR)=8.8] years and 31 [IQR=29.3] kg, respectively. Over one year, 65 (22%) children presented with ≥1 complication, with Clavien-Dindo ≥III in 14/300 (5%) children at ≤30 days, 7/300 (2%) at 30-90 days, and 12/300 (4%) at >90 days. Perioperative transfusion was necessary in 15 (5%) children, mostly oncological (n=8). Eight (3%) robotic malfunctions were noted, one leading to conversion (laparotomy). Overall conversion rate was 4%. ASA ≥3, weight ≤15 kg, and surgical oncology did not significantly increase the conversion rate, complications, or intraoperative adverse events (ClassIntra ≥2). ASA score was significantly higher in children with complications (Clavien-Dindo ≥III) than without (p=0.01). Median hospital stay was 2 [IQR=3] days. Three children died after a median follow-up of 20 [IQR=16] months.

CONCLUSIONS

RALS is safe, even in the most vulnerable children with a wide scope of indications, age, and weight. Robot-specific complications or malfunctions are scarce.